Nov 10 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2023 Sep 30, 2022 Mar 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 5.53 5.65 13.50
(-2.2 pct) (-5.5 pct) (+12.1 pct)
Operating loss 464 mln loss 346 mln 390 mln
Recurring loss 463 mln loss 324 mln 400 mln
Net loss 345 mln loss 230 mln 250 mln
EPS loss 91.33 yen loss 61.02 yen 66.11 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T